Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Toludesvenlafaxine for non-specific low back pain

Official title: Efficacy and Safety of Toludesvenlafaxine in the Treatment of Non-specific Low Back Pain

Run by Beijing Tiantan Hospital · NCT07709416 · Data updated 2026-11-12

This study tests toludesvenlafaxine to help adults with chronic non-specific low back pain see if it reduces their pain.

More Chronic Non-specific Low Back Pain trials

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment132 (estimated)
SponsorBeijing Tiantan Hospital
Academic / other
Locations1 site (Beijing)
StatusRecruiting
StartedJuly 15, 2026
Main results expectedSeptember 1, 2028
Study endsDecember 1, 2028
Registry record updatedJuly 27, 2026
Trial IDNCT07709416 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 to 75 with chronic non-specific low back pain (pain below the costal margin and above the inferior gluteal folds) lasting more than 3 months and moderate to severe intensity (NRS ≥ 3), without depression or prior antidepressant use.

Probably not a fit

Patients with depression, prior antidepressant use, opioid use, or specific spinal pathology may not benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study evaluates toludesvenlafaxine as an active comparator for adults with chronic non-specific low back pain. Participants are adults 18 to 75 with moderate to severe pain lasting at least 3 months and no identifiable spinal pathology. The trial focuses on pain reduction as the primary outcome, using standard pain scales, under controlled conditions to compare toludesvenlafaxine with a reference treatment. Exclusion criteria include depression, prior antidepressant use, opioid use, and other conditions that could confound results. The lead sponsor is Beijing Tiantan Hospital, with recruitment centered in Beijing, China.

Why it matters

Potential benefit: If successful, Toludesvenlafaxine could provide an effective option for reducing chronic non-specific low back pain and improving quality of life.

How similar studies have gone: Prior research in similar antidepressant classes has shown mixed results for chronic low back pain; this study aims to clarify toludesvenlafaxine's role.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18 to 75 years.
* Diagnosis of chronic nonspecific low back pain, defined as pain located below the costal margin and above the inferior gluteal folds, lasting for more than 3 months, without a specific pathological cause.
* Moderate to severe pain, defined as a Numerical Rating Scale score of 3 or higher.
* Able to understand the study procedures and sign written informed consent.

Exclusion Criteria:

* Low back pain caused by a known specific pathological condition, including but not limited to fracture, malignancy, infection, inflammatory disease, or other identifiable structural or systemic causes.
* Major comorbidities that may interfere with study outcomes or represent contraindications to the study medication.
* Current or previous diagnosis of depression, regardless of whether treatment was received.
* Current or previous use of antidepressant medication.
* Current use of opioid analgesics.
* Pregnancy, breastfeeding, or planned pregnancy during the study period.
* Known allergy, hypersensitivity, or contraindication to toludesvenlafaxine.
* History of psychosis or other major psychiatric disorders.
* Any condition that, in the investigator's judgment, makes the participant unsuitable for the study.

Where it's running

  • Fang Luo
    Beijing, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.